(781) 222-1022 | [email protected]

Biosafety

Biosafety

We have been getting many questions from clients on appropriate precautions to take when working with COVID-19 positive samples in the lab. The World Organization (WHO), the Centers for Disease Control and Prevention (CDC), the Public Health Agency of Canada (PHAC), and the American Biological Safety Association (ABSA)  have all published extremely informative guidance on this topic
Prevent Blindness, the nation’s first eye health and vision care nonprofit organization, has deemed March as Workplace Eye Wellness Month. Did you know that thousands of people are blinded each year from work-related eye injuries? According to the CDC, each day about 2,000 U.S. employees sustain a work-related eye injury that requires medical treatment.
If your facility is registered with the MA DEP as a Large Quantity Generator (LQG) of hazardous waste, don’t forget that 2020 is a year when biennial reports must be filed.  Biennial reports are due by March 1st of even numbered years for any facility that exceeded the LQG threshold during the preceding odd numbered year, even if your facility is no longer registered as an LQG.
Did you know that violations related to the OSHA Hazard Communication standard ranked #2 in the OSHA top 10 list for most frequently cited violations in 2018? Common citations included not having a written program or safety data sheets (SDS) for all chemicals, lack of employee training, and deficiencies related to secondary container labels.
The use of fresh blood drawn from company employees is sometimes required when timelines in experiments are too tight to use an outside blood supply vendor. That said, it is considered to be preferable from a safety standpoint, and often a logistical one as well, that an outside blood supply vendor be used rather than establishing an in-house program.